Myths vs. Facts: Getting Hemgenix (Etranacogene Dezaparvovec) Covered by Cigna in New York
Answer Box: Getting Hemgenix Covered by Cigna in New York
Eligibility: Male patients ≥18 with severe hemophilia B (Factor IX ≤2%), ≥150 exposure days, negative AAV5 antibodies, and normal liver function qualify for Cigna coverage under policy IP_0535.
Fastest path: Submit prior authorization with complete lab documentation (Factor IX